Stockscreener 앱 받기
8.63
2.74%
0.23
시간 외 거래:
8.65
0.02
+0.23%
Exagen Inc 주식(XGN)의 최신 뉴스
What drives Exagen Inc. stock priceFree Stock Market Beginners Guide - jammulinksnews.com
What are the latest earnings results for Exagen Inc.Discover breakthrough trading strategies - jammulinksnews.com
What makes Exagen Inc. stock price move sharplyCapitalize on market trends before they peak - jammulinksnews.com
Is Exagen Inc. a good long term investmentMaximize your gains with expert trading tips - jammulinksnews.com
What are Exagen Inc. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com
What are analysts’ price targets for Exagen Inc. in the next 12 monthsSuperior returns - jammulinksnews.com
What is the risk reward ratio of investing in Exagen Inc. stockBreakthrough profit margins - jammulinksnews.com
What catalysts could drive Exagen Inc. stock higher in 2025Build wealth steadily with smart stock selection - jammulinksnews.com
Is Exagen Inc. a growth stock or a value stockInvest smarter with advanced market data - jammulinksnews.com
Is Exagen Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - jammulinksnews.com
Is it the right time to buy Exagen Inc. stockRemarkably fast returns - jammulinksnews.com
What is the dividend policy of Exagen Inc. stockUnmatched profit potential - jammulinksnews.com
Applying big data sentiment scoring on Exagen Inc.Momentum Trend Signal Weekly Recap Summary - Newser
Exagen outlines $65M–$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline - MSN
Exagen Inc. (NASDAQ:XGN) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Exagen Inc. stock outlook for YEARStock Performance Summary Over One Year - Newser
Is Exagen Inc. reversing from oversold territoryStrong Buy Signal Summary with Entry Zone - Newser
Exagen Inc. Reports Record Revenue Amidst Growth Challenges - The Globe and Mail
What markets is Exagen Inc. expanding into Is LILA stock a good long term investment optionExpert Picks Data Feed For Consistent Profits - jammulinksnews.com
What risks could impact Exagen Inc. stock performanceDaily Upside Movement Prediction With Data - Newser
Published on: 2025-07-31 02:36:55 - Newser
Exagen Analyst Ratings: Bullish Sentiment Dominates - AInvest
Exagen's Q2 Growth Validates Buy Rating, Analyst Says - AInvest
Exagen price target raised to $11 from $8 at Canaccord - TipRanks
Exagen price target raised to $10 from $7 at Cantor Fitzgerald - TipRanks
Canaccord Genuity Sticks to Its Buy Rating for Exagen (XGN) - The Globe and Mail
Exagen stock price target raised to $10 from $7 at Cantor Fitzgerald - Investing.com Nigeria
KeyBanc upgrades Exagen on improved revenue visibility - TipRanks
Visual analytics tools that track Exagen Inc. performanceLow Risk Stock Selection Strategy Guide - Newser
KeyBanc upgrades Exagen stock to Overweight on improved pricing and growth - Investing.com Nigeria
Chart based analysis of Exagen Inc. trendsTop Stock Picks with Forecast Accuracy - Newser
Key metrics from Exagen Inc.’s quarterly dataHigh Probability Trade Outcome Prediction - Newser
Why Exagen Inc. stock attracts strong analyst attentionLow Risk Stock Selection Strategy Guide - Newser
Exagen Reports Record Q2 2025 Revenue of $17.2M, Announces Strategic Updates - AInvest
Exagen Inc. Reports Record Q2 2025 Revenue - TipRanks
Exagen 2025 Q2 Earnings Misses Targets as Net Loss Widens 49.7% - AInvest
Exagen Q2 Revenue Jumps 14 Percent - AOL.com
Exagen's Q2 2025: Unpacking Contradictions in Volume Growth, ASP Expectations, and Biopharma Revenue - AInvest
Exagen Inc. To Announce Second Quarter 2025 Financial Results On July 29, 2025 - Barchart.com
Exagen Q2 Revenue Up 14% to $17.2mln, Net Loss Widens to $4.4mln - AInvest
Earnings call transcript: Exagen Q2 2025 revenue surpasses expectations - Investing.com
Earnings call transcript: Exagen Q2 2025 revenue surpasses expectations By Investing.com - Investing.com Canada
EXAGEN INC. SEC 10-Q Report - TradingView
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Exagen earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Exagen’s Revenue Rises, But Profit Remains Elusive In Q2 - Finimize
Exagen Inc. Reports Strong Q2 2025 Results - The Manila Times
Published on: 2025-07-29 06:38:44 - Newser
How Exagen Inc. stock performs during market volatilitySafe Entry Strategy with High Win Rate - Newser
0.54%
2.95%
자본화:
|
볼륨(24시간):